Lv1
48 积分 2025-03-11 加入
Testing for Trend in Benefit-Risk Analysis with Prioritized Multiple Outcomes
1个月前
已完结
Trial Design with Win Statistics for Multiple Time-to-Event Endpoints with Hierarchy
1个月前
已完结
Regression Analysis of Restricted Mean Survival Time Based on Pseudo-Observations
1个月前
已完结
Analysis of a modified surgical desirability of outcome ranking (mDOOR) among patients undergoing surgery for Hepatocellular carcinoma
1个月前
已关闭
Comparing an experimental agent to a standard agent: relative merits of a one-arm or randomized two-arm Phase II design
1个月前
已完结
Optimizing the FDA’s Project Optimus: opportunities and challenges
1个月前
已完结
Surrogate end points in oncology: the speed–uncertainty trade-off from the patients’ perspective
1个月前
已完结
From Dose-Finding to Dose-Optimization in Early-Phase oncology clinical trials
1个月前
已完结
Optimal two-stage designs for phase II clinical trials
1个月前
已完结
Design Strategy and Consideration for Oncology Dose-Optimization: An Industry Perspective
1个月前
已完结
皖公网安备34019202002308
